MacroGenics, Inc.
MGNX
$3.08
-$0.02-0.65%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.16M | 16.82M | -36.25M | -41.04M | -15.42M |
| Total Depreciation and Amortization | 1.71M | 1.79M | 1.91M | 1.77M | 2.05M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.33M | 3.44M | 4.37M | 4.60M | -27.67M |
| Change in Net Operating Assets | 53.14M | -52.24M | -17.01M | -12.23M | 2.63M |
| Cash from Operations | 43.02M | -30.19M | -46.99M | -46.89M | -38.41M |
| Capital Expenditure | -244.00K | -426.00K | -715.00K | -529.00K | -620.00K |
| Sale of Property, Plant, and Equipment | 11.00K | -- | -- | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -65.76M | -19.95M | -36.92M | 10.43M | 42.09M |
| Cash from Investing | -65.99M | -20.37M | -37.64M | 9.90M | 41.47M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 63.00K | 0.00 | 66.00K | -- | 159.00K |
| Repurchase of Common Stock | -6.00K | 0.00 | 0.00 | -282.00K | -4.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 69.67M | -- | -- |
| Cash from Financing | 57.00K | 0.00 | 69.74M | -282.00K | 155.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.91M | -50.56M | -14.88M | -37.27M | 3.22M |